Evidence map›Paper›PMID 20032219›Full record

ArticleClinical and vaccine immunology : CVI2010

Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever.

Peter M Schneeberger, Mirjam H A Hermans, Erik J van Hannen, Jeroen J A Schellekens, Alexander C A P Leenders, Peter C Wever

Abstract readEvaluation Study
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular frequency ofNew microbes and new infections · 2026
    Article
  7. Public health challenges · 2026
    Article
  8. Article
  9. Impact ofFrontiers in veterinary science · 2026
    Article
  10. Molecular characterization ofFrontiers in veterinary science · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Molecular assessment ofIranian journal of microbiology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Molecular Detection ofJournal of arthropod-borne diseases · 2024
    Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peter M SchneebergerJeroen Bosch Hospital, Department of Medical Microbiology and Infection Control, P.O. Box 90153, 5200 ME 's-Hertogenbosch, The Netherlands. p.schneeberger@jbz.nl
Mirjam H A Hermans
Erik J van Hannen
Jeroen J A Schellekens
Alexander C A P Leenders
Peter C Wever

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The world's largest Q fever outbreak is ongoing in The Netherlands with around 3,000 confirmed cases since the first half of 2007. Increased awareness has resulted in early referral of patients for diagnostics. An important drawback to serological diagnosis of acute Q fever is the lag phase in antibody response. Therefore, we evaluated the performance of a real-time PCR for detection of Coxiella burnetii DNA using serum samples from patients with acute Q fever. PCR, targeting IS1111, was retrospectively performed on acute-phase and follow-up convalescent-phase serum samples from 65 patients with acute Q fever as diagnosed by immunofluorescence assay. The results obtained by PCR were related to disease stage as defined by subsequent appearance of phase II IgM, phase II IgG, phase I IgM, and phase I IgG (IgM-II, IgG-II, IgM-I, and IgG-I, respectively) antibodies and time since onset of disease. In addition, we analyzed seronegative acute-phase serum samples from patients with inconclusive Q fever serology, because no convalescent-phase serum samples were available. PCR was scored positive in 49/50 (98%) seronegative sera, 9/10 (90%) sera with isolated IgM-II antibodies, 3/13 (23%) sera with IgM-II/IgG-II antibodies, 2/41 (5%) sera with IgM-II/IgG-II/IgM-I antibodies, 0/15 (0%) sera with IgM-II/IgG-II/IgM-I/IgG-I antibodies, and 0/1 (0%) serum sample with IgM-II/IgG-II/IgG-I antibodies. The latest time point after onset of disease in which C. burnetii DNA could be detected was at day 17. In patients with inconclusive Q fever serology, PCR was positive in 5/50 (10%) cases. We conclude that real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. C. burnetii DNA becomes undetectable in serum as the serological response develops.

Indexed as

AdolescentAdultAntibodies, BacterialClinical Laboratory TechniquesCoxiella burnetiiDNA, BacterialDNA PrimersDNA Transposable ElementsEarly DiagnosisHumansImmunoglobulin GImmunoglobulin MNetherlandsPolymerase Chain ReactionQ FeverSensitivity and SpecificityAntibodies, BacterialDNA, BacterialDNA PrimersDNA Transposable ElementsImmunoglobulin GImmunoglobulin M

Identifiers

PMID20032219
PMCPMC2815520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.